7713-77-1

Basic information

• Product Name: 3H-Pyrazol-3-one, 1,2-dihydro-4,5-dimethyl-2-phenyl-
• CAS NO: 7713-77-1
• Molecular Formula: C11H12N2O
• Molecular Weight: 188.229
• Mol File: 7713-77-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3H-Pyrazol-3-one, 1,2-dihydro-4,5-dimethyl-2-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 3H-Pyrazol-3-one, 1,2-dihydro-4,5-dimethyl-2-phenyl-(7713-77-1)
• EPA Substance Registry System: 3H-Pyrazol-3-one, 1,2-dihydro-4,5-dimethyl-2-phenyl-(7713-77-1)

Safety Data

• Hazardous Substances Data: 7713-77-1(Hazardous Substances Data)

Upstream product

• 914353-87-0 (5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-acetic acid 
• 609-14-3 2-acetylpropanoic acid ethyl ester 
• 100-63-0 phenylhydrazine 
• 67-56-1 methanol 
• 19735-89-8 3-methyl-1-phenylpyrazolin-5(4H)-one 
• 124-41-4 sodium methylate 
• 74-88-4 methyl iodide 
• 7647-01-0 hydrogenchloride 
• 166949-11-7 5-methoxy-3,4-dimethyl-1-phenyl-1H-pyrazole 

Downstream Products

• 16190-63-9 1-phenyl-2-benzyl-3,4-dimethyl-5-pyrazolone 
• 5677-84-9 1,4,5-trimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one 
• 116436-00-1 3,4-dimethyl-1-phenyl-1H-pyrazole 
• 25543-79-7 4-iodo-4,5-dimethyl-2-phenyl-2,4-dihydro-pyrazol-3-one 
• 96172-44-0 4,4',5,5'-tetramethyl-2,2'-diphenyl-2,2',4,4'-tetrahydro-3H,3'H-[4,4'-bipyrazole]-3,3'-dione 
• 2969-29-1 meso-3,3',4,4'-tetramethyl-1,1'-diphenyl-[4,4'-bipyrazol]-5,5'-dione 
• 1241995-51-6 3,4-dimethyl-4-(2-nitro-1-phenylethyl)-1-phenyl-1H-pyrazol-5(4H)-one 

Relevant articles and documents

Mild Nitration of Pyrazolin-5-ones by a Combination of Fe(NO3)3 and NaNO2: Discovery of a New Readily Available Class of Fungicides, 4-Nitropyrazolin-5-ones

4-Nitropyrazolin-5-ones have been synthesized by the nitration of pyrazolin-5-ones at room temperature by employing the Fe(NO3)3/NaNO2 system. The method demonstrated selectivity towards the 4-position of pyrazolin-5-ones

PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, X, and n are as defined for Formula (I) in the description, processes for the preparation of the compounds and new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and the use of the compounds in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction.